Cargando…
Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers
Cognitive impairment is frequently reported among anti-phospholipid syndrome (APS) patients as well as anti-phospholipid antibody (aPL) carriers, but it is less studied than other manifestations of this condition. Moreover, the exact prevalence of cognitive impairment in these patients has not been...
Autores principales: | Hassan, Fadi, Naffaa, Mohammad E., Saab, Amir, Putterman, Chaim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870021/ https://www.ncbi.nlm.nih.gov/pubmed/35203985 http://dx.doi.org/10.3390/brainsci12020222 |
Ejemplares similares
-
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
por: Borghi, Maria Orietta, et al.
Publicado: (2020) -
A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome
por: Vaidya, Binit, et al.
Publicado: (2019) -
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases
por: Nalli, Cecilia, et al.
Publicado: (2018) -
Avidity of anti-phospholipid antibodies in relation to their levels
por: FIALOVÁ, LENKA, et al.
Publicado: (2020) -
Atypical Presentation of Anti-Phospholipid Antibody Syndrome with Seizure and Atrial Mass
por: Shil, Rajish Sanjit Kumar, et al.
Publicado: (2020)